MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 103 filers reported holding MIRUM PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,709 | -48.7% | 1,573 | -58.0% | 0.00% | – |
| Q2 2023 | $96,807 | +97.8% | 3,742 | +83.6% | 0.00% | – |
| Q1 2023 | $48,952 | +245.3% | 2,038 | +180.3% | 0.00% | – |
| Q4 2022 | $14,177 | +1.3% | 727 | +7.7% | 0.00% | – |
| Q3 2022 | $14,000 | +27.3% | 675 | +18.8% | 0.00% | – |
| Q2 2022 | $11,000 | -21.4% | 568 | -12.6% | 0.00% | – |
| Q1 2022 | $14,000 | -99.3% | 650 | -99.4% | 0.00% | – |
| Q2 2021 | $1,977,000 | -12.8% | 114,328 | 0.0% | 0.00% | – |
| Q1 2021 | $2,266,000 | -18.5% | 114,328 | -28.2% | 0.00% | – |
| Q4 2020 | $2,780,000 | -32.4% | 159,228 | -25.4% | 0.00% | – |
| Q3 2020 | $4,115,000 | -10.0% | 213,564 | -9.1% | 0.00% | -100.0% |
| Q2 2020 | $4,573,000 | +39.0% | 235,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,290,000 | – | 235,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,566,912 | $62,278,000 | 4.80% |
| RiverVest Venture Management LLC | 1,921,118 | $33,543,000 | 3.68% |
| Burrage Capital Management LLC | 161,628 | $2,822,000 | 2.15% |
| AIGH Capital Management LLC | 274,583 | $4,794,000 | 1.95% |
| NEA Management Company, LLC | 4,187,801 | $73,119,000 | 1.93% |
| Novo Holdings A/S | 2,445,147 | $42,692,000 | 1.83% |
| Sio Capital Management, LLC | 494,743 | $8,638,000 | 1.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,448,912 | $60,218,000 | 1.19% |
| Rock Springs Capital Management LP | 1,496,525 | $26,129,000 | 0.55% |
| Prosight Management, LP | 60,250 | $1,052,000 | 0.49% |